Volume 18 – Number 4

Minimal Requirements for Primary HIV Latency Models Based on a Systematic Review

Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys?

HIV/HCV Coinfection in Taiwan

Body Fat Changes in People Living with HIV on Antiretroviral Therapy

HIV and HCV Therapies in 2016: Optimal Regimens

HIV Pre-Exposure Prophylaxis – Is it just about pills?

Reactivation of Hepatitis B in HIV Patients Treated for Hepatitis C

Risk of HIV Escape using Sub-Optimal Antiretroviral Dual or Monotherapy

HIV Guidelines

HIV Conferences